See more : Urstadt Biddle Properties Inc. (UBP-PH) Income Statement Analysis – Financial Results
Complete financial analysis of MariMed Inc. (MRMD.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MariMed Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- The Western India Plywoods Limited (WIPL.NS) Income Statement Analysis – Financial Results
- Carbon Revolution Public Limited Ordinary Shares (CREV) Income Statement Analysis – Financial Results
- Renold plc (RNO.L) Income Statement Analysis – Financial Results
- Pioneer High Income Fund, Inc. (PHT) Income Statement Analysis – Financial Results
- Batero Gold Corp. (BELDF) Income Statement Analysis – Financial Results
MariMed Inc. (MRMD.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.marimedinc.com
About MariMed Inc.
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 148.60M | 134.01M | 121.46M | 50.90M | 45.60M | 11.85M | 6.07M | 3.56M | 1.27M | 88.38K | 904.00 | 785.00 | 125.61K |
| Cost of Revenue | 82.68M | 70.05M | 55.20M | 19.57M | 26.90M | 4.04M | 2.56M | 1.35M | 1.30M | 190.17K | 26.29K | 19.95K | 23.03K |
| Gross Profit | 65.92M | 63.96M | 66.26M | 31.32M | 18.70M | 7.81M | 3.51M | 2.21M | -33.54K | -101.78K | -25.38K | -19.16K | 102.58K |
| Gross Profit Ratio | 44.36% | 47.73% | 54.55% | 61.55% | 41.01% | 65.90% | 57.88% | 62.07% | -2.64% | -115.16% | -2,807.63% | -2,441.15% | 81.67% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 93.11K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 44.74M | 35.14M | 35.91M | 15.40M | 12.73M | 11.54M | 3.25M | 1.31M | 1.20M | 695.57K | 438.76K | 591.62K | 476.24K |
| Selling & Marketing | 5.98M | 3.74M | 1.63M | 410.63K | 369.58K | 292.48K | 130.09K | 293.49K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 50.84M | 38.88M | 37.54M | 15.81M | 13.10M | 11.84M | 3.38M | 1.60M | 1.20M | 695.57K | 438.76K | 591.62K | 476.24K |
| Other Expenses | 695.00K | -127.00K | 306.67K | -84.71K | 2.95M | -2.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 51.53M | 38.88M | 37.54M | 15.81M | 13.10M | 11.84M | 3.38M | 1.60M | 1.66M | 715.57K | 532.76K | 755.62K | 476.24K |
| Cost & Expenses | 134.21M | 108.93M | 92.74M | 35.38M | 40.00M | 15.88M | 5.94M | 2.95M | 2.96M | 905.73K | 559.05K | 775.57K | 499.27K |
| Interest Income | 270.00K | 959.00K | 108.22K | 156.35K | 467.80K | 593.21K | 0.00 | 56.50K | 56.15K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.19M | 1.69M | 2.36M | 9.81M | 12.72M | 4.37M | 511.52K | 347.34K | 206.56K | 56.20K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 8.57M | 4.71M | 2.79M | 2.18M | 1.20M | 657.85K | 362.69K | 265.75K | 1.21M | 20.00K | -22.54K | 34.75K | 3.75K |
| EBITDA | 11.16M | 26.04M | 29.65M | 16.71M | -20.12M | -2.82M | 490.34K | 877.48K | -434.34K | -797.35K | -535.61K | -740.03K | -369.91K |
| EBITDA Ratio | 7.51% | 22.86% | 26.29% | 35.10% | -44.11% | -23.79% | 8.08% | 26.21% | -33.73% | -902.14% | -64,234.73% | -94,271.85% | -294.50% |
| Operating Income | 14.39M | 20.37M | 26.86M | 14.53M | 5.60M | -4.02M | 1.21M | 611.73K | -1.69M | -817.35K | -558.15K | -774.79K | -373.66K |
| Operating Income Ratio | 9.68% | 15.20% | 22.12% | 28.55% | 12.29% | -33.95% | 19.87% | 17.16% | -133.10% | -924.77% | -61,741.70% | -98,698.98% | -297.48% |
| Total Other Income/Expenses | -20.98M | -861.00K | -3.05M | -10.03M | -40.28M | -7.95M | -1.16M | -290.57K | -156.33K | -6.60M | 22.54K | -34.75K | -3.75K |
| Income Before Tax | -6.60M | 19.51M | 23.82M | 4.50M | -81.88M | -13.31M | -1.03M | 321.17K | -1.85M | -7.42M | -535.61K | -809.54K | -377.41K |
| Income Before Tax Ratio | -4.44% | 14.56% | 19.61% | 8.83% | -179.55% | -112.29% | -16.96% | 9.01% | -145.41% | -8,396.65% | -59,248.45% | -103,126.11% | -300.47% |
| Income Tax Expense | 9.41M | 5.89M | 16.19M | 2.07M | -15.36M | 5.76M | 676.54K | 867.35K | -425.01K | -145.55K | 0.00 | 0.00 | 0.00 |
| Net Income | -16.03M | 13.47M | 7.23M | 2.14M | -66.52M | -19.07M | -1.19M | -198.85K | -1.22M | -7.22M | -535.61K | -809.54K | -377.41K |
| Net Income Ratio | -10.79% | 10.05% | 5.95% | 4.21% | -145.86% | -160.90% | -19.68% | -5.58% | -95.68% | -8,168.38% | -59,248.56% | -103,126.11% | -300.47% |
| EPS | -0.04 | 0.04 | 0.02 | 0.01 | -0.32 | -0.10 | -0.01 | 0.00 | -0.04 | -0.23 | -0.02 | -0.04 | -1.04 |
| EPS Diluted | -0.04 | 0.04 | 0.02 | 0.01 | -0.32 | -0.10 | -0.01 | 0.00 | -0.04 | -0.23 | -0.02 | -0.04 | -1.04 |
| Weighted Avg Shares Out | 363.40M | 380.29M | 361.25M | 324.16M | 208.17M | 192.38M | 116.28M | 52.02M | 31.98M | 31.90M | 30.33M | 19.81M | 361.72K |
| Weighted Avg Shares Out (Dil) | 363.40M | 380.29M | 372.40M | 324.16M | 208.72M | 192.38M | 116.28M | 52.02M | 31.98M | 31.90M | 30.33M | 19.81M | 361.72K |
Source: https://incomestatements.info
Category: Stock Reports